Prostacyclin administration suppresses the increase in hepatic levels of COL1A(I) and glyceraldehyde-3-phosphate dehydrogenase mRNAs in the rat treated with carbon tetrachloride

Biochem Biophys Res Commun. 1992 Jun 30;185(3):981-6. doi: 10.1016/0006-291x(92)91723-4.

Abstract

Northern analysis using total RNAs from the component cells of normal rat liver indicated that COL1A(I) mRNA is present in fat-storing cells (Ito cells) and sinusoidal endothelial cells. A fraction for Kupffer cells also contained this mRNA. When CCl4 was given, COL1A(I) mRNA was increased in a factor of 1.5 in the fractions of these component cells. After 48 h of the drug administration, hepatocytes appeared to possess over 60% of liver COL1A(I) mRNA, although in normal hepatocytes its level was below the range detectable by our procedures. Under this injured condition of liver, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA level was elevated, while activity of this enzyme was lowered by 50% of the control value. All the changes were obviously suppressed by the simultaneous administration of prostacyclin.

MeSH terms

  • Animals
  • Carbon Tetrachloride / pharmacology*
  • Carbon Tetrachloride Poisoning / metabolism*
  • Collagen / genetics*
  • Glyceraldehyde-3-Phosphate Dehydrogenases / genetics*
  • Kinetics
  • Liver / drug effects
  • Liver / metabolism*
  • Male
  • RNA, Messenger / genetics
  • RNA, Messenger / isolation & purification
  • RNA, Messenger / metabolism*
  • Rats
  • Rats, Inbred Strains

Substances

  • RNA, Messenger
  • Collagen
  • Carbon Tetrachloride
  • Glyceraldehyde-3-Phosphate Dehydrogenases